With COVID-19 Surging Again, Hospital and Pharmacist Groups Back Employee Vaccine Mandates

Groups whose members include 340B hospitals have thrown their support behind mandatory COVID-19 vaccination policies for hospital and health system personnel.

Groups whose members include 340B hospitals have thrown their support behind mandatory COVID-19 vaccination policies for hospital and health system personnel.

The Association of American Medical Colleges (AAMC) on July 16 urged its member institutions to require vaccinations for

Read More »

For 340B Hospitals, Some Consolation in Otherwise Disappointing CMS Drug Reimbursement Rule

CMS proposes extending "pass-through" status for 24 drugs and three biosimilars in 2022—a move that would temporarily shield the medicines from the deep payment cut for 340B hospitals.

Hospitals groups were deeply disappointed last week with the U.S. Centers for Medicare & Medicaid Services’ (CMS) proposal to continue a nearly 30% cut in Medicare Part B reimbursement for hospitals’ 340B purchased drugs in place since 2018.

Another provision

Read More »

340B Contract Pharmacy Litigation Could Drag on for Years, Hospital Group Leader Says

It could take federal courts years to ultimately resolve drug manufacturers’ 340B contract pharmacy lawsuits, 340B Health President and CEO Maureen Testoni said yesterday.

It could take federal courts years to ultimately resolve drug manufacturers’ lawsuits over whether they must charge lower prices when 340B covered entities use contract pharmacies, a hospital association leader said yesterday during her remarks opening the 340B Coalition’s virtual

Read More »

Pedley Provides 340B Update but Avoids Contract Pharmacy Controversy

Due to litigation, 340B program director Rear Adm. Krista Pedley could say little about the drug discount program during yesterday’s 340B Coalition virtual summer conference.

Rear Adm. Krista Pedley, Director of the U.S. Health Resources and Services Administration’s (HRSA) Office of Pharmacy Affairs (OPA), gave a brief update on the 340B program during yesterday’s 340B Coalition virtual summer conference. She explained that “due to current

Read More »

House GOP Starts Crafting Health Care Bills in Anticipation of Retaking Majority

Rep. Brett Guthrie (R-Ky.) will run to chair the House E&C Committee next session--and is considered by some lobbyists as the favorite to win--if Republicans maintain control of the House.

The top Republicans on two U.S. House health subcommittees are leading a party effort to “craft legislative proposals that Republicans can advance after retaking the majority” in the November 2022 midterm elections. It is not known whether the group will

Read More »

340B Program Flexibilities to Continue As COVID-19 Emergency Extended

HHS Secretary Xavier Becerra this week extended the COVID-19 public health emergency until mid-October.

U.S. Health and Human Services (HHS) Secretary Xavier Becerra on Monday extended the COVID-19 national public health emergency (PHE) for another 90 days, to Oct. 17. The move extends 340B program flexibilities implemented during the pandemic’s early days.

In

Read More »

With 340B Hospital Recertification Set to Begin Soon, HRSA To Host Webinar Aug. 11

Annual recertification of hospital eligibility for 340B drug discounts begins on Aug. 16.

The recertification period for hospitals to continue to participate in the 340B program begins in mid-August. The U.S. Health Resources Services Administration (HRSA) has scheduled an informational webinar on Wednesday, Aug. 11 at 1 p.m. Eastern time to discuss the

Read More »

Thriving with HIV: How a Compassionate Pharmacy Technician Made All the Difference

SPONSORED CONTENT by Tyler Curry-McGrath, Avita Pharmacy

A patient newly diagnosed with HIV can often feel as if the cards are stacked against them before they even begin. Overcoming the fear and stigma of telling loved ones, finding the right doctor, navigating the insurance process, starting and staying in care—the journey ahead can seem like an impossible one. Even the smallest obstacles along the way can lead to non-adherence to treatment, dropping out of care, and worse health outcomes.

Hearing the words from my doctor’s mouth, you have HIV, was gut wrenching. Waiting for my first doctor’s appointment after my diagnosis, I honestly can’t remember what I was thinking. All I can remember is the fear.

My doctor was wonderful, patiently answering my frantic questions one after the other. Slowly my breathing normalized, my mind stopped racing, and I was ready to start my treatment. I left with a prescription and a co-pay card in hand and went straight to the closest pharmacy in my neighborhood.

Still

Read More »

Biden Administration’s Proposal to Retain 340B Hospital Drug Payment Cuts Draws More Fire

Groups whose members include 340B hospitals yesterday slammed CMS for proposing to continue deep drug payment cuts to 340B hospitals.

Several groups whose members include 340B hospitals yesterday slammed the Biden administration’s proposal to continue the Trump administration’s huge cut in Medicare Part B reimbursement for hospitals’ 340B purchased drugs.

The new administration yesterday announced its proposed plans for

Read More »

One-Fourth of 340B DSH Hospitals at Risk of Losing Eligibility Due to Pandemic, Analysis Finds

Many hospitals reduced inpatient admissions during the COVID-19 pandemic. 340B hospitals now fear that this could cause them to lose their eligibility for 340B drug discounts due to changes in patient mix.

Roughly one out of four 340B disproportionate share (DSH) hospitals could lose their eligibility for 340B drug discounts due to COVID-19 pandemic-related changes in patient mix, an analysis of hospital Medicare cost reports for 2019 and 2020 shows. About one

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report